Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.

Yan D, Hutchison RE, Mohi G.

Blood. 2012 Aug 30;120(9):1888-98. doi: 10.1182/blood-2011-09-380808. Epub 2012 Jul 26.

2.

JAK2 and MPL mutations in myeloproliferative neoplasms.

Koppikar P, Levine RL.

Acta Haematol. 2008;119(4):218-25. doi: 10.1159/000140634. Epub 2008 Jun 20. Review.

PMID:
18566540
3.

JAK-2 mutations and their relevance to myeloproliferative disease.

Levine RL, Gilliland DG.

Curr Opin Hematol. 2007 Jan;14(1):43-7. Review.

PMID:
17133099
4.
5.

Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.

Prick J, de Haan G, Green AR, Kent DG.

Exp Hematol. 2014 Oct;42(10):841-51. doi: 10.1016/j.exphem.2014.07.268. Epub 2014 Sep 6. Review.

PMID:
25201757
6.

[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].

Chen YX, Li Y, Zhang LY, Liu B.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1329-33. Review. Chinese.

PMID:
22040998
7.

Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.

Sun T, Zhang L.

Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):374-81. doi: 10.1177/1076029612453761. Epub 2012 Jul 23. Review.

PMID:
22826442
8.

Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders.

Levine RL, Wernig G.

Hematology Am Soc Hematol Educ Program. 2006:233-9, 510. Review.

PMID:
17124066
9.

A role for JAK2 mutations in myeloproliferative diseases.

Morgan KJ, Gilliland DG.

Annu Rev Med. 2008;59:213-22. Review.

PMID:
17919086
11.

After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera.

Grinfeld J, Godfrey AL.

Blood Rev. 2017 May;31(3):101-118. doi: 10.1016/j.blre.2016.11.001. Epub 2016 Nov 15. Review.

PMID:
27884555
12.

JAK2 mutation and thrombosis in the myeloproliferative neoplasms.

Vannucchi AM.

Curr Hematol Malig Rep. 2010 Jan;5(1):22-8. doi: 10.1007/s11899-009-0038-x. Review.

PMID:
20425393
13.

Mouse models of myeloproliferative neoplasms: JAK of all grades.

Li J, Kent DG, Chen E, Green AR.

Dis Model Mech. 2011 May;4(3):311-7. doi: 10.1242/dmm.006817. Review.

Supplemental Content

Support Center